But I think BTH really has a more specific issue on his mind, ARIA's Rida. which was first developed as an IV formulation then replaced with an oral version.
This one has me confused as well. It seams more reasonable to go forward with the IV unless there is something we all are missing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.